- Home
- JLRF Award
JLRF Award
The 2020 Japan Leukemia Research Fund Award were given to 13 researchers and 2 groups this year.
Ogimura Takashi Special Prize
- Tomoya Muto
- [Department of Hematology, Chiba University Hospital]
- “The role of innate immune signaling in the pathogenesis of hematopoietic malignancies”
Shimizu Award
- Toshihiko Imamura
- [Department of Pediatrics, Kyoto Prefectural University of Medicine Graduate School of Medical Science]
- “Functional analysis of IKZF1 deletion in a development of ph-like acute lymphoblastic leukemia”
Credit Saison Award
- Yusuke Furukawa
- [Division of Stem Cell Regulation, Jichi Medical University]
- “Development of novel therapeutic agents for high-risk multiple myeloma targeting histone methyltransferase MMSET”
Ide Award
- Hiroshi Kobayashi
- [Research Institute, National Center for Global Health and Medicine]
- “Development of gene editing methods that do not impair the function of hematopoietic stem cells”
Special Award --- Clinical Medicine Special Award（In no particular order）
- Yotaro Ochi
- [Department of Pathology and Tumor Biology, Kyoto University]
- “Aberrant transcription and novel drug target in leukemia”
- Chihaya Imai
- [Department of Pediatrics, Graduate School of Medical and Dental Science, Niigata University]
- “An exploratory study to investigate molecular and immunological determinants associated with efficacy of bispecific antibody blinatumomab against newly diagnosed high risk B-lineage acute lymphoblastic leukemia”
General Research Award（In no particular order）
- Naoki Hosen
- [Department of Hematology and Oncology, Osaka University Graduate School of Medicine]
- “Development of novel CAR-T cell therapy for hematological cancer”
- Satoru Miyagi
- [Department of Life Science, Faculty of Medicine, Shimane University]
- “The molecular function of PHF6 in normal hematopoiesis and leukemogenesis”
- Minoru Takata
- [Laboratory of Genome Damage Signaling, Radiation Biology Center, Graduate school of Biostudies, Kyoto University]
- “Genome destabilizing mechanism in Fanconi anemia: DNA damage sensitization by SLFN11 gene leading to hematopoietic failure and leukemogenesis”
- Takako Miyamura
- [Department of Pediatrics, Osaka University Graduate School of Medicine]
- “Nationwide survey of congenital leukemia /Elucidation of pathogenesis of congenital leukemia using genome analysis”
- Akira Nishimura
- [Tokyo Medical and Dental University]
- “Clarification of molecular pathogenesis and development of molecular targeted therapies for myeloid/natural killer cell precursor acute leukemia”
- Yuki Kagoya
- [Division of Immune Response, Aichi Cancer Center Research Institute]
- “Development of chimeric antigen receptor engineered T cell therapy for acute myelogenous leukemia”
- Mayumi Hirayama
- [Laboratory Medicine, Kumamoto University Hospital]
- “Roles of RNA helicase in leukemogenesis: involvement of DDX41 gene mutation in R-loop formation and DNA damage response”
- Hiromi Yamazaki
- [Institute of Biomedical Research and Innovation]
- “Development of a treatment for acute myeloid leukemia targeting amino acid metabolism”
Mainichi Award
- JCCG
- [Japan Children’s Cancer Group]
- Hiroyuki Ishida
- [Division of Pediatric Hematology, Kyoto City Hospital]
- “Phase II study of allogeneic hematopoietic cell transplantation for children with acute myeloid leukemia in first and second complete remission using fludarabine, cytarabine, melphalan and low-dose total body irradiation as conditioning regimen (AML-SCT15)”
